Additionally, NF1 mutation status was significantly predicted by contrast-enhancing volume and tumor bulk volume, whereas PDGFR-α was significantly predicted by T2-FLAIR hyperintensity/total tumor volume and tumor bulk/total tumor volume ratios. This evidence concerns the gene NF1 and neoplasm.